Phase I trial investigating the pharmacokinetics and tolerability of LX 1033 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2011
At a glance
- Drugs LX 1033 (Primary)
- Indications Irritable bowel syndrome
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 28 Jul 2011 Status changed from recruiting to completed, according to a Lexicon Pharmaceuticals media release.
- 12 May 2011 New trial record